Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

QR Code

Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

Saved in:

Bibliographic Details
Main Authors:	Antonio E. Muruato, Camila R. Fontes-Garfias, Ping Ren, Mariano A. Garcia-Blanco, Vineet D. Menachery, Xuping Xie, Pei-Yong Shi
Format:	article
Language:	EN
Published:	Nature Portfolio 2021
Subjects:	Science Q
Online Access:	https://doaj.org/article/f56e9cc29e60462cb6e3893494f198df
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
by: Antonio E. Muruato, et al.
Published: (2020)

Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
by: Xuping Xie, et al.
Published: (2021)

The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
by: Jing Zou, et al.
Published: (2021)

Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay
by: Zhu-Nan Li, et al.
Published: (2021)

Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
by: Deli Huang, et al.
Published: (2020)

A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies
by: Adrian Creanga, et al.
Published: (2021)

A competitive ligand-binding assay for the detection of neutralizing antibodies against dostarlimab (TSR-042)
by: Xiaolong Tom Zhang, et al.
Published: (2021)

Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines
by: Youchun Wang
Published: (2021)

High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay
by: Markus H. Kainulainen, et al.
Published: (2021)

Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
by: Deli Huang, et al.
Published: (2020)

A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
by: Patthara Kongsuphol, et al.
Published: (2021)

Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
by: Zhiqiang Ku, et al.
Published: (2021)

Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
by: Chaojie Zhong, et al.
Published: (2021)

Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
by: Cong Zeng, et al.
Published: (2021)

FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge
by: Craig Miller, et al.
Published: (2018)

Optimizing use of multi-antibody assays for Lyme disease diagnosis: A bioinformatic approach.
by: Richard Porwancher, et al.
Published: (2021)

HtrA3 as an early marker for preeclampsia: specific monoclonal antibodies and sensitive high-throughput assays for serum screening.
by: Kemperly Dynon, et al.
Published: (2012)

Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques
by: Michael K. McCracken, et al.
Published: (2021)

SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
by: Mikail Dogan, et al.
Published: (2021)

Optimization of Flow-Cytometry Based Assay for Measuring Neutralizing Antibody Responses against Each of the Four Dengue Virus Serotypes
by: Pragati Sharma, et al.
Published: (2021)

Diagnostic value of islet autoantibody assays practised in Russia. 1. Classic immunofluorescence islet cell antibody assay, immunoradiometric glutamic acid decarboxylase antibody assay, and ELISA tyrosine phosphatase antibody and insulin antibody assays
by: Alexei V. Timofeev, et al.
Published: (2016)

Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
by: Tiago Abreu-Mota, et al.
Published: (2018)

Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses
by: Lars E. Clark, et al.
Published: (2018)

A high-throughput assay for quantitative measurement of PCR errors
by: Dmitriy A. Shagin, et al.
Published: (2017)

Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection
by: Fan Zhou, et al.
Published: (2021)

Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
by: Zhiqiang Ku, et al.
Published: (2021)

Influenza Virus Resistance to Human Neutralizing Antibodies
by: James E. Crowe
Published: (2012)

Orthobunyavirus spike architecture and recognition by neutralizing antibodies
by: Jan Hellert, et al.
Published: (2019)

The Divider Assay is a high-throughput pipeline for aggression analysis in Drosophila
by: Budhaditya Chowdhury, et al.
Published: (2021)

Precision multidimensional assay for high-throughput microRNA drug discovery
by: Benjamin Haefliger, et al.
Published: (2016)

Semi-Automated High-Throughput Substrate Screening Assay for Nucleoside Kinases
by: Katja F. Hellendahl, et al.
Published: (2021)

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
by: Lin Cheng, et al.
Published: (2021)

Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history
by: Thomas W. McDade, et al.
Published: (2021)

Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization
by: Jin Wang, et al.
Published: (2021)

Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
by: Thomas Krey, et al.
Published: (2013)

Vaccine genetics of IGHV1-2 VRC01-class broadly neutralizing antibody precursor naïve human B cells
by: Jeong Hyun Lee, et al.
Published: (2021)

Use of Quantitative Dried Blood Spots to Evaluate the Post-Vaccination Level of Neutralizing Antibodies against SARS-CoV-2
by: Alexandre Marchand, et al.
Published: (2021)

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies
by: Niraj Mishra, et al.
Published: (2020)

The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies.
by: Devin Sok, et al.
Published: (2013)

Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
by: Qifeng Han, et al.
Published: (2019)